Assessment of UL56 Mutations before Letermovir Therapy in Refractory Cytomegalovirus Transplant Recipients
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Assessment of UL56 Mutations before Letermovir Therapy in Refractory Cytomegalovirus Transplant Recipients
Authors
Keywords
-
Journal
Microbiology Spectrum
Volume 10, Issue 2, Pages -
Publisher
American Society for Microbiology
Online
2022-03-28
DOI
10.1128/spectrum.00191-22
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phenotype and genotype study of novel C480F maribavir-ganciclovir cross-resistance mutation detected in hematopoietic stem cell and solid organ transplanted patients
- (2021) Marta Santos Bravo et al. JOURNAL OF INFECTIOUS DISEASES
- Drug resistance mutations and associated phenotypes detected in clinical trials of maribavir for treatment of cytomegalovirus infection
- (2020) Sunwen Chou et al. JOURNAL OF INFECTIOUS DISEASES
- Use of Letermovir as Salvage Therapy for Drug-resistant CMV Retinitis: A Case Series
- (2019) Nicholas Turner et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Letermovir Resistance Analysis in a Clinical Trial of Cytomegalovirus Prophylaxis for Hematopoietic Stem Cell Transplant Recipients
- (2019) Cameron M Douglas et al. JOURNAL OF INFECTIOUS DISEASES
- De Novo Genotypic Heterogeneity in the UL56 Region in Cytomegalovirus-Infected Tissues: Implications for Primary Letermovir Resistance
- (2019) Horim Jo et al. JOURNAL OF INFECTIOUS DISEASES
- A New Locus of Drug Resistance in the Human Cytomegalovirus UL56 Gene Revealed by in vitro Exposure to Letermovir and Ganciclovir
- (2018) Sunwen Chou et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Drug-resistant cytomegalovirus
- (2018) Raymund R. Razonable Current Opinion in Organ Transplantation
- The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation
- (2018) Camille N. Kotton et al. TRANSPLANTATION
- Detection of cytomegalovirus drug resistance mutations in solid organ transplant recipients with suspected resistance
- (2017) Rubén López-Aladid et al. JOURNAL OF CLINICAL VIROLOGY
- Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
- (2017) Francisco M. Marty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Contrasting effect of new HCMV pUL54 mutations on antiviral drug susceptibility: Benefits and limits of 3D analysis
- (2016) D. Andouard et al. ANTIVIRAL RESEARCH
- RapidIn VitroEvolution of Human Cytomegalovirus UL56 Mutations That Confer Letermovir Resistance
- (2015) Sunwen Chou ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Improved Detection of Emerging Drug-Resistant Mutant Cytomegalovirus Subpopulations by Deep Sequencing
- (2014) Sunwen Chou et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Human cytomegalovirus (CMV) susceptibility to currently approved antiviral drugs does not impact on CMV terminase complex polymorphism
- (2014) Léa Pilorgé et al. ANTIVIRAL RESEARCH
- Cytomegalovirus UL97 Kinase Catalytic Domain Mutations That Confer Multidrug Resistance
- (2013) Sunwen Chou et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro and In Vivo Activities of the Novel Anticytomegalovirus Compound AIC246
- (2010) P. Lischka et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antiviral Drug Resistance of Human Cytomegalovirus
- (2010) N. S. Lurain et al. CLINICAL MICROBIOLOGY REVIEWS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started